MetLife Investment Management, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 100 filers reported holding ANTARES PHARMA INC in Q2 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$345,208
+165.4%
84,197
+131.1%
0.00%
+100.0%
Q4 2021$130,055
-40.8%
36,430
-39.7%
0.00%
-50.0%
Q3 2021$219,743
+26.8%
60,369
+51.8%
0.00%0.0%
Q2 2021$173,341
-36.9%
39,757
-40.5%
0.00%
-33.3%
Q1 2021$274,601
+46.5%
66,813
+42.3%
0.00%
+50.0%
Q4 2020$187,402
+83.8%
46,968
+24.4%
0.00%
+100.0%
Q3 2020$101,952
-46.7%
37,760
-45.7%
0.00%
-50.0%
Q2 2020$191,348
+16.5%
69,5810.0%0.00%0.0%
Q1 2020$164,211
-49.8%
69,5810.0%0.00%
-33.3%
Q4 2019$327,031
+40.5%
69,5810.0%0.00%0.0%
Q3 2019$232,748
+1.7%
69,5810.0%0.00%0.0%
Q2 2019$228,921
+8.6%
69,5810.0%0.00%
+50.0%
Q1 2019$210,830
+11.4%
69,5810.0%0.00%0.0%
Q4 2018$189,260
-19.0%
69,5810.0%0.00%0.0%
Q3 2018$233,792
+26.4%
69,581
-3.0%
0.00%0.0%
Q2 2018$185,000
+17.1%
71,7310.0%0.00%0.0%
Q1 2018$158,000
+327.0%
71,731
+281.1%
0.00%
Q4 2017$37,00018,8200.00%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
JW Asset Management, LLC 1,820,524$4,697,0003.00%
ARMISTICE CAPITAL, LLC 12,050,000$31,089,0002.03%
Broadfin Capital, LLC 4,623,247$11,928,0001.88%
Healthcare Value Capital, LLC 100,000$258,0000.73%
Healthcare Value Capital, LLC 100,000$258,0000.73%
MYCIO WEALTH PARTNERS, LLC 2,433,500$6,278,0000.65%
PERKINS CAPITAL MANAGEMENT INC 317,500$819,0000.59%
Brown Advisory Securities, LLC 275,000$710,0000.12%
FALCON POINT CAPITAL, LLC 222,501$574,0000.11%
Avenir Corp 291,597$752,0000.09%
View complete list of ANTARES PHARMA INC shareholders